Free carnitine and branched chain amino acids are not good biomarkers in Huntington’s disease

Minimal prevalence of Huntington’s disease in the South of Brazil and instability of the expanded CAG tract during intergenerational transmissions

(2019) Raphael Machado de Castilhos et al.   GENETICS AND MOLECULAR BIOLOGY

Integration of targeted metabolomics and transcriptomics identifies deregulation of phosphatidylcholine metabolism in Huntington’s disease peripheral blood samples

(2016) Anastasios Mastrokolias et al.   Metabolomics

The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions

(2015) Ashraf Virmani et al.   MOLECULAR NEUROBIOLOGY

Huntington disease and Huntington disease-like in a case series from Brazil

(2013) R.M. Castilhos et al.   CLINICAL GENETICS

Serum carnitine levels and levocarnitine supplementation in institutionalized Huntington’s disease patients

(2012) Miroslav Cuturic et al.   NEUROLOGICAL SCIENCES

Validation of Plasma Branched Chain Amino Acids as Biomarkers in Huntington Disease

(2011) Fanny Mochel et al.   ARCHIVES OF NEUROLOGY

Mitochondrial matters of the brain: the role in Huntington’s disease

(2010) C. Turner et al.   JOURNAL OF BIOENERGETICS AND BIOMEMBRANES

Carnitine Insufficiency Caused by Aging and Overnutrition Compromises Mitochondrial Performance and Metabolic Control

(2009) Robert C. Noland et al.   JOURNAL OF BIOLOGICAL CHEMISTRY